Amnog Benefit Assessment: Time Delay of Market Access for Pharmaceuticals in Germany?
Saved in:
Published in: | Value in health Vol. 16; no. 7; p. A475 |
---|---|
Main Authors: | , , , |
Format: | Journal Article |
Language: | English |
Published: |
01-11-2013
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Author | Voss, P Gmeiner, A Neubauer, A.S Neubauer, G |
---|---|
Author_xml | – sequence: 1 fullname: Neubauer, A.S – sequence: 2 fullname: Voss, P – sequence: 3 fullname: Gmeiner, A – sequence: 4 fullname: Neubauer, G |
BookMark | eNotkMFOwzAQRH0oEm3hBzj5BxK8dpykHEClQEEqAon2bDnuGpI2DrLbSvl7HJXTSqOZ0eybkJHrHBJyAywFBvltkzYnvU85A5GyMi1LOSJjYLMyEQzkJZmE0DDGcsHlmGzmreu-6SM6tPWBzkPAEFp0hzu6rlukT7jXPe0sfdd-h9FgTDRQ23n6-aN9qw0eD7XR-0BrR5cYFdc_XJELGyW8_r9Tsnl5Xi9ek9XH8m0xXyUGMi4TyNBwU0KFUHIOspICgJlCYmU4csurvMqlKLa5zdAWYltYzAVWWlZZYbKZmBJ-7jW-C8GjVb--brXvFTA1wFCNGmCoAYZipYowYuj-HMK47FSjV2Zfu-GHHfYYmu7oXRytQAWumPoa0A3kQDBezJgQfx1FbJw |
ContentType | Journal Article |
DBID | AAYXX CITATION |
DOI | 10.1016/j.jval.2013.08.885 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology |
EndPage | A475 |
ExternalDocumentID | 10_1016_j_jval_2013_08_885 1_s2_0_S1098301513027903 |
GroupedDBID | --- --K --M .1- .3N .FO .GA .Y3 .~1 0R~ 0SF 10A 123 1OC 1P~ 1~. 29Q 31~ 36B 4.4 44B 457 4G. 51W 51X 52N 52P 52R 52S 52X 53G 5LA 5VS 66C 6I. 6PF 7-5 7PT 8-1 8P~ 8UM AACTN AAEDT AAEDW AAFJI AAFTH AAFWJ AAHHS AAIKJ AAKOC AALRI AAOAW AAPFB AAQFI AAQXK AAWTL AAXKI AAXUO ABBQC ABCQN ABDBF ABEML ABIVO ABJNI ABMAC ABMMH ABMZM ABVKL ABXDB ACCFJ ACDAQ ACGFS ACHQT ACPRK ACRLP ACXQS ADBBV ADEZE ADFHU ADMUD ADVLN AEBSH AEEZP AEKER AENEX AEQDE AEVXI AEXQZ AEYQN AFBPY AFCTW AFEBI AFJKZ AFKWA AFRHN AFTJW AFXIZ AFZJQ AGHFR AGTHC AGUBO AGYEJ AIEXJ AIIAU AIKHN AITUG AIWBW AJAOE AJBDE AJOXV AJRQY AJUYK AKRWK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX AOMHK ASPBG AVARZ AVWKF AXJTR AXLSJ AZFZN BAWUL BFHJK BKOJK BLXMC BNPGV BY8 CAG CO8 COF CS3 DCZOG DIK DU5 EAD EAP EBS EFJIC EJD EMB EMK EMOBN ESX F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN GBLVA HF~ HVGLF HZI HZ~ IHE IXB KOM M41 MO0 N9A NCXOZ O-L O9- OAUVE OIG OK1 OVD P-8 P-9 P2P PC. PQQKQ PRBVW Q38 QB0 R2- RIG ROL SDF SEL SES SPCBC SSB SSF SSH SSO SSZ SUPJJ SV3 T5K TEORI TUS W99 WYUIH XG1 YFH Z5R ~G- AAYXX CITATION |
ID | FETCH-LOGICAL-c1425-14ec2c81be182215b53110c75ebc2e2f2b6b6537d6f4ef73d7fe63eba5b47c493 |
ISSN | 1098-3015 |
IngestDate | Thu Sep 26 17:10:55 EDT 2024 Tue Oct 15 22:56:05 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c1425-14ec2c81be182215b53110c75ebc2e2f2b6b6537d6f4ef73d7fe63eba5b47c493 |
OpenAccessLink | http://www.valueinhealthjournal.com/article/S1098301513027903/pdf |
ParticipantIDs | crossref_primary_10_1016_j_jval_2013_08_885 elsevier_clinicalkeyesjournals_1_s2_0_S1098301513027903 |
PublicationCentury | 2000 |
PublicationDate | 2013-11-00 |
PublicationDateYYYYMMDD | 2013-11-01 |
PublicationDate_xml | – month: 11 year: 2013 text: 2013-11-00 |
PublicationDecade | 2010 |
PublicationTitle | Value in health |
PublicationYear | 2013 |
SSID | ssj0006325 |
Score | 2.0658183 |
SourceID | crossref elsevier |
SourceType | Aggregation Database Publisher |
StartPage | A475 |
SubjectTerms | Internal Medicine |
Title | Amnog Benefit Assessment: Time Delay of Market Access for Pharmaceuticals in Germany? |
URI | https://www.clinicalkey.es/playcontent/1-s2.0-S1098301513027903 |
Volume | 16 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3Nb9MwFLe6TUJcEAwQ40s-oF26VEnsxAkXFEboAIEmrUO7WbVjQ6s1RWQ59L_nOXY-1g0JkLikrZVE7nu__J6f8z4QeiVCosBKB14UmJQcWVAvlfPYE6IIqRSMyaZk_skZ-3KRvMtpPhq1HcD6sf-qaRgDXZvM2b_QdndTGIDvoHM4gtbh-Ed6z1bl-tv4LVCYXlyNs67wZrOPvliZMKHL-cZGvpiEZ9MvwrCdCTc8_T7c4G4iZaeGucvNVvzf1_ll3VQbsWmU_Y5yLea164896Zt5uc7sXSrZdKUWLtEmu-3a6XAvIiAuKa-nT1OdFCgjusav8QBHbECWGbVNU5zhbX_eIHW7v7CcLEEbJhiPmKKrSRL1Jqx9bZ8ffwq8Kpz43pmZiplJ82I29cn1k63_w6uQ-_zGqTtoDz4J8OVe9iG_-NhZ9pg0TXy7f-mSsGy84Pbsbl_oDBYvs_vonvM6cGbh8gCNVLmP7nx2cRX76NBpfnOEZ31CXnWED_FpX9t88xCdN_DCDl64h9drbMCFG3DhtcYWXNiCCwO48Ba48KLEDlxvHqHz9_ns-MRznTk8GQDJewFVMpTg8ShwT2HRKIDJA1-ySAkZqlCHIhZxRFgRa6o0IwXTKiZKzCNBmaQpeYx2y3WpniBM_aZPEhGF0lTKKEl9nYbgJUgttaL6AI1bMfIftgALbyMTl9wInRuhcz_hIPQDxFpJ8za1GIyhqtwTWvHfKf3pP1_5DN3tn4XnaPfqZ61eoJ2qqF86AP0CEvmOPg |
link.rule.ids | 315,783,787,27936,27937 |
linkProvider | Elsevier |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Amnog+Benefit+Assessment%3A+Time+Delay+of+Market+Access+for+Pharmaceuticals+in+Germany%3F&rft.jtitle=Value+in+health&rft.au=Neubauer%2C+A.S&rft.au=Voss%2C+P&rft.au=Gmeiner%2C+A&rft.au=Neubauer%2C+G&rft.date=2013-11-01&rft.issn=1098-3015&rft.volume=16&rft.issue=7&rft.spage=A475&rft.epage=A475&rft_id=info:doi/10.1016%2Fj.jval.2013.08.885&rft.externalDBID=ECK1-s2.0-S1098301513027903&rft.externalDocID=1_s2_0_S1098301513027903 |
thumbnail_m | http://sdu.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F10983015%2FS1098301513X00075%2Fcov150h.gif |